Tracheal smooth muscle (TSM) (TSM)

Tracheal smooth muscle is a primary structural component located on the posterior aspect of the trachea, responsible for maintaining airway tone and regulating the diameter of the respiratory conduit. It functions primarily through contraction and relaxation in response to autonomic innervation and local inflammatory mediators, thereby modulating airway resistance [1, 2, 9]. In health, it maintains a baseline tone, while in disease states like asthma and chronic obstructive pulmonary disease (COPD), it undergoes pathological remodeling characterized by hypertrophy and hyperplasia [8, 13, 16]. This structural change contributes significantly to airway hyperresponsiveness and the persistent airflow limitation observed in obstructive lung diseases [8, 9]. Pharmacologically, tracheal smooth muscle is a major therapeutic target; drugs such as beta-2 adrenergic agonists (e.g., salbutamol) promote its relaxation, while muscarinic antagonists (e.g., ipratropium) prevent its contraction [2, 3, 15]. Beyond its mechanical role, the tissue also acts as an immunomodulatory organ by secreting cytokines and chemokines that sustain airway inflammation [10, 15, 16].

Other names

Airway smooth muscleASMTrachealis muscleParabronchial smooth muscle

Drugs target various molecular pathways within tracheal smooth muscle to modulate airway tone; Beta-2 adrenergic agonists increase intracellular cAMP via Gs-coupled receptors to promote relaxation, while muscarinic antagonists block acetylcholine-mediated contraction through M3 receptors, and leukotriene receptor antagonists prevent contraction induced by cysteinyl leukotrienes [2, 3, 15, 17].